Latest News by Industry
SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — FibroGen Inc. (FGEN) on Monday reported a loss of $76.7 million in its first quarter.
On a per-share basis, the San Francisco-based company said it had a loss of 81 cents.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 76 cents per share.
The biotech drug developer posted revenue of $36.2 million in the period, which topped Street forecasts. Four analysts surveyed by Zacks expected $30.9 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a FGEN">Zacks stock report on FGEN at https://www.zacks.com/ap/FGEN